Cargando…
The Safety and Efficiency of Addressing ARDS Using Stem Cell Therapies in Clinical Trials
Acute Respiratory Distress Syndrome (ARDS) is a complex and debilitating disease of the lungs, which continues to have a high mortality rate and huge disease burden on patients. Incidence is rising, possibly due to greater awareness leading to more diagnoses rather than a change in the underlying ra...
Autores principales: | Rezoagli, Emanuele, Murphy, Emma J., Laffey, John, O’Toole, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121814/ http://dx.doi.org/10.1007/978-3-030-29403-8_12 |
Ejemplares similares
-
β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects — Implications for coronavirus disease (COVID-19) immunotherapies
por: Murphy, Emma J., et al.
Publicado: (2020) -
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020) -
Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014) -
β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application
por: Murphy, Emma J., et al.
Publicado: (2020) -
The Severe ARDS Generating Evidence (SAGE) Study: A Call for Action in the Daily Clinical Practice
por: Rezoagli, Emanuele, et al.
Publicado: (2021)